Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HW-N2001 Injection for Peptic Ulcer Bleeding Phase III Trial
CTR20260111Phase 3Active
- Sponsor
- Shandong Daohe Pharmaceutical
- Start
- Jan 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of hemocoagulase agkistrodon in Peptic ulcer disease (PUD), sponsored by Shandong Daohe Pharmaceutical. Started Jan 2026; status: active.
02
Drugs
hemocoagulase agkistrodon
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20260111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260111.